ALISITY

Serial Number 98415302
730

Registration Progress

Application Filed
Feb 21, 2024
Under Examination
Nov 26, 2024
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Nov 26, 2025 126 days

Trademark Image

ALISITY

Basic Information

Serial Number
98415302
Filing Date
February 21, 2024
Published for Opposition
October 15, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 28, 2025
Application
Pending
Classes
005

Rights Holder

PRIOVANT THERAPEUTICS, INC.

03
Address
151 W. 42ND STREET
15TH FLOOR
NEW YORK, NY 10036

Ownership History

PRIOVANT THERAPEUTICS, INC.

Original Applicant
03
NEW YORK, NY

PRIOVANT THERAPEUTICS, INC.

Owner at Publication
03
NEW YORK, NY

Legal Representation

Attorney
Lisa L. Mueller

USPTO Deadlines

Next Deadline
126 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 26, 2025
Extension Available
Until November 26, 2025

Application History

12 events
Date Code Type Description Documents
Apr 29, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 28, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 28, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 28, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 11, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 11, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 27, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease

Classification

International Classes
005